predominant autoantibody production early human b cell precursors 
b lymphocyte development antibodies assembled random gene segment reassortment produce vast number specificities potential disadvantage process antibodies produced self-reactive determined prevalence self-reactive antibody formation regulation human b cells majority % antibodies expressed early immature b cells displayed self-reactivity including poly-reactive anti-nuclear specificities autoantibodies removed population two discrete checkpoints b cell development inefficient checkpoint regulation lead substantial increases circulating autoantibodies 
